Get Live Data

Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in CanadaView Video
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. SLN.L Share Price
  4. SLN.L Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksSLN.L Share News (SLN)

SLN.L Information
  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 05th Aug 2021 16:18

Friday 6 August 
ContourGlobal PLCHalf Year Results
FBD Holdings PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Irish Residential Properties REIT PLCHalf Year Results
London Stock Exchange Group PLCHalf Year Results
Renewables Infrastructure Group LtdHalf Year Results
Monday 9 August 
Clarkson PLCHalf Year Results
Griffin Mining LtdHalf Year Results
H&T Group PLCHalf Year Results
Hargreaves Lansdown PLCFull Year Results
Kosmos Energy PLCQ2 Results
PageGroup PLCHalf Year Results
TI Fluid Systems PLCHalf Year Results
Tuesday 10 August 
abrdn PLCHalf Year Results
Bellway PLCTrading Statement
Derwent London PLCHalf Year Results
Flutter Entertainment PLCHalf Year Results
Gamesys Group PLCHalf Year Results
InterContinental Hotels Group PLCHalf Year Results
IWG PLCHalf Year Results
M&G PLCHalf Year Results
Marshall Motor Holdings PLCHalf Year Results
S&U PLCTrading Statement
Watches of Switzerland Group PLCTrading Statement
Zotefoams PLCHalf Year Results
Wednesday 11 August 
4imprint Group PLCHalf Year Results
Aberdeen New India Investment Trust PLCFull Year Results
Admiral Group PLCHalf Year Results
Atalaya Mining PLCHalf Year Results
Avast PLCHalf Year Results
CLS Holdings PLCHalf Year Results
Deliveroo PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hill & Smith Holdings PLCHalf Year Results
Hostelworld Group PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
Provident Financial PLCHalf Year Results
Prudential PLCHalf Year Results
Quilter PLCHalf Year Results
RPS Group PLCHalf Year Results
Spirax-Sarco Engineering PLCHalf Year Results
Vaalco Energy IncQ2 Results
Thursday 12 August 
Arix Bioscience PLCHalf Year Results
Arrow Global Group PLCHalf Year Results
Aviva PLCHalf Year Results
Coca-Cola HBC AGHalf Year Results
Empiric Student Property PLCHalf Year Results
Glanbia PLCHalf Year Results
Just Group PLCHalf Year Results
Mears Group PLCHalf Year Results
Silence Therapeutics PLCHalf Year Results
Tribal Group PLCHalf Year Results
Tui AGQ3 Results
Vitec Group PLCHalf Year Results
Wheaton Precious Metals CorpQ2 Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Nov 2021 12:59

IN BRIEF: Silence Therapeutics to delist from AIM next week

IN BRIEF: Silence Therapeutics to delist from AIM next week

Read more
26 Nov 2021 09:53

Silence Therapeutics to proceed with AIM delisting next week

(Sharecast News) - Silence Therapeutics updated the market on the planned cancellation of its shares on AIM on Friday, which it originally announced on 15 October.

Read more
16 Nov 2021 12:23

TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note

TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note

Read more
16 Nov 2021 11:39

Revenue, expenses rise in third quarter for Silence Therapeutics

(Sharecast News) - Silence Therapeutics said on Tuesday that its revenue increased by £1.2m year-on-year in its third quarter, as a result of the further advancement of its partner programmes, as well as the introduction of additional programmes with its partners.

Read more
5 Nov 2021 18:40

IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics

IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics

Read more
5 Nov 2021 11:39

Frazier Life Sciences becomes 'important' new Silence Therapeutics shareholder

(Sharecast News) - Novel short interfering ribonucleic acid (siRNA) therapy developer Silence Therapeutics announced on Friday that healthcare-focussed investor Frazier Life Sciences Public Fund had purchased about $20m of its existing shares.

Read more
25 Oct 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
22 Oct 2021 20:26

IN BRIEF: Silence Therapeutics reports solid progress across pipelines

IN BRIEF: Silence Therapeutics reports solid progress across pipelines

Read more
15 Oct 2021 15:40

CORRECT: Silence Therapeutics to delist from AIM; teams with Hansoh

CORRECT: Silence Therapeutics to delist from AIM; teams with Hansoh

Read more
15 Oct 2021 14:15

IN BRIEF: Silence Therapeutics to delist from AIM; unites with Hansoh

IN BRIEF: Silence Therapeutics to delist from AIM; unites with Hansoh

Read more
15 Oct 2021 12:23

Silence Therapeutics inks collaboration deal with Hansoh Pharmaceutical

(Sharecast News) - Silence Therapeutics announced a collaboration with Hansoh Pharmaceutical Group on Friday, to develop short interfering ribonucleic acids (siRNAs) for three undisclosed targets, leveraging its proprietary 'mRNAi GOLD' platform.

Read more
1 Sep 2021 09:30

Silence promotes John Strafford to head new product development

(Sharecast News) - Silence Therapeutics announced the appointment of John Strafford to the newly-created role of senior vice-president of business development, alliance management and new product development on Wednesday, effective immediately.

Read more
12 Aug 2021 13:56

IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca

IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca

Read more
12 Aug 2021 09:37

Silence Therapeutics losses widen as it progresses programmes

(Sharecast News) - Silence Therapeutics reported revenues from collaborations of £5.8m in its first half on Thursday, up from £1.1m year-on-year, which it put down to its work with AstraZeneca and Mallinckrodt.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.